Topiramate — an antiseizure medication prescribed to treat epilepsy as well as migraines and bipolar disorder — does not appear to increase the risk of autism spectrum disorder (ASD) among children exposed to it prenatally, according to a new study led by Harvard T.H. Chan School of Public Health.

Harvard Gazette article on new research from Kathryn Rexrode and colleagues, first author Alexandra C Purdue-Smithe, finding that women with pre-pregnancy migraines have a greater risk of complications, including preterm delivery, gestational hypertension, and pre-eclampsia.